Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 6 Months and up

Using Ketorolac to improve recovery after palatoplasty for cleft lip and palate

Official title: Ketorolac in Palatoplasty: A Randomized Blinded Controlled Trial.

Run by The University of Texas Health Science Center, Houston · NCT04771156 · Data updated 2026-11-12

This study tests if giving Ketorolac along with regular pain relief can help patients recover better and eat more easily after surgery for cleft lip and palate.

More Cleft Lip and Palate trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages6 Months and up
SexAll
Enrollment74 (estimated)
SponsorThe University of Texas Health Science Center, Houston
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedSeptember 17, 2021
Main results expectedMarch 1, 2027
Study endsApril 1, 2027
Registry record updatedFebruary 19, 2026
Trial IDNCT04771156 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with cleft palate, either complete or incomplete, who are scheduled for palatoplasty.

Probably not a fit

Patients with syndromic cleft palate, previous palatoplasty, or significant medical history that contraindicates NSAID use may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of intravenous Ketorolac as an addition to standard multi-modal pain management in patients undergoing palatoplasty for cleft lip and palate. The goal is to determine if this intervention can enhance oral intake following surgery compared to usual care alone. Participants will be randomly assigned to receive either Ketorolac or a placebo, allowing for a controlled comparison of outcomes. The study focuses on patients with both complete and incomplete cleft palates, with or without associated cleft lip.

Why it matters

Potential benefit: If successful, this approach could lead to improved recovery and oral intake for patients undergoing palatoplasty.

How similar studies have gone: Other studies have explored the use of NSAIDs in post-operative pain management, showing promising results, but this specific application of Ketorolac in palatoplasty is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

-Patient with Cleft palate (Complete and incomplete), with or without cleft lip, unilateral or bilateral

Exclusion Criteria:

* Syndromic Cleft Palate patients
* Previous palatoplasty
* Major unrepaired cardiac malformation
* History of GI complications (GI Bleed, Gastric Ulceration)
* History of Renal disorder
* History of coagulopathy (As contraindication to NSAID use)
* Feeding tube dependency
* Patients whose parents refuse to consent to randomization

Where it's running

  • The University of Texas Health Science Center at Houston
    Houston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Matthew R Grieves, MD,MS,FACS — The University of Texas Health Science Center, Houston
  • Study coordinator: Matthew R Greives, MD,MS,FACS
  • Email: Matthew.R.Greives@uth.tmc.edu
  • Phone: (713) 500-7275

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.